| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1998;65:1207-1214
© 1998 The Society of Thoracic Surgeons
a Clinic of Cardiovascular Surgery, Department of Surgery, University Hospital, Zurich, Switzerland
b Division of Cardiology, Department of Medicine, University Hospital, Zurich, Switzerland
Address reprint requests to Dr Schönbeck, Clinic of Cardiovascular Surgery, University Hospital, Raemistrasse 100, CH-8091 Zurich, Switzerland
Presented at the Thirty-third Annual Meeting of The Society of Thoracic Surgeon, San Diego, CA, Feb 3–5, 1997.
Background. Controversy exists about the choice of treatment for patients with hypertrophic obstructive cardiomyopathy. The purpose of this study was to evaluate clinical and echocardiographic long-term results in patients with hypertrophic obstructive cardiomyopathy after septal myectomy and to determine predictors of event-free survival in these patients.
Methods. Between 1965 and 1995, 110 consecutive patients 2 to 66 years old (mean age, 37 ± 15 years) with an invasively measured left ventricular outflow tract gradient of 86 ± 39 mm Hg (81 ± 42 mm Hg by Doppler echocardiography) underwent either septal myectomy only (n = 87) or myectomy combined with additional procedures (n = 23). Mean follow-up was 11.7 ± 7.5 years. Predictors of late events were calculated using multivariate Cox regression analysis.
Results. The perioperative mortality rate was 3.6% (n = 4). The cumulative survival rate at 5, 10, and 15 years was 93%, 80%, and 72%, respectively, and symptom-free survival, 77%, 50%, and 33%, respectively. Predictors of late death were New York Heart Association class III or IV (p < 0.05), congestive heart failure (p < 0.05) and additional procedures (p < 0.05). The left ventricular outflow tract gradient was nearly eliminated in all patients, the left atrial dimension decreased significantly during the early years, and left ventricular dilatation occurred late in 17 patients.
Conclusions. Septal myectomy is associated with a low perioperative mortality and a high late survival rate (72% at 15 years’ follow-up). Septal myectomy is still an excellent modality in the treatment strategy for symptomatic patients with hypertrophic obstructive cardiomyopathy.
This article has been cited by other articles:
|
|
 |
|
  M. A. Fifer and G. J. Vlahakes Management of Symptoms in Hypertrophic Cardiomyopathy Circulation, January 22, 2008; 117(3): 429 - 439. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Fifer Most Fully Informed Patients Choose Septal Ablation Over Septal Myectomy Circulation, July 10, 2007; 116(2): 207 - 216. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ashrafian, M. J. Mason, and A. G. Mitchell Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing Europace, January 1, 2007; 9(1): 50 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Minakata, J. A. Dearani, P. W. O'Leary, and G. K. Danielson Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy in Pediatric Patients: Early and Late Results Ann. Thorac. Surg., October 1, 2005; 80(4): 1424 - 1430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Minakata, J. A. Dearani, H. V. Schaff, P. W. O'Leary, S. R. Ommen, and G. K. Danielson Mechanisms for Recurrent Left Ventricular Outflow Tract Obstruction After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy Ann. Thorac. Surg., September 1, 2005; 80(3): 851 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Ommen, B. J. Maron, I. Olivotto, M. S. Maron, F. Cecchi, S. Betocchi, B. J. Gersh, M. J. Ackerman, R. B. McCully, J. A. Dearani, et al. Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., August 2, 2005; 46(3): 470 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ralph-Edwards, A. Woo, B. W. McCrindle, J. L. Shapero, L. Schwartz, H. Rakowski, E. D. Wigle, and W. G. Williams Hypertrophic obstructive cardiomyopathy: Comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 351 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Minakata, J. A. Dearani, R. A. Nishimura, B. J. Maron, and G. K. Danielson Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 481 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Schoen and R. F. Padera Jr. Cardiac Surgical Pathology Card. Surg. Adult, January 1, 2003; 2(2003): 119 - 185. [Full Text]
|
|
|
|
 |
|
 K. Minami, D. Boethig, H. Woltersdorf, D. Seifert, and R. Korfer Long term follow-up of surgical treatment of hypertrophic obstructive cardiomyopathy (HOCM): the role of concomitant cardiac procedures Eur. J. Cardiothorac. Surg., August 1, 2002; 22(2): 206 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Maron Hypertrophic Cardiomyopathy: A Systematic Review JAMA, March 13, 2002; 287(10): 1308 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Seshadri, G. M. Novaro, H. Lever, R. D. White, N. Smedira, R. A. Grimm, and M. J. Garcia Myectomy site thrombus formation: An underappreciated source of thromboembolism after septal myectomy J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 562 - 564. [Full Text] [PDF]
|
|
|
|
 |
|
 W Ruzyllo, L Chojnowska, M Demkow, A Witkowski, B Kusmierczyk-Droszcz, W Piotrowski, L Rausinska, M Karcz, L Malecka, and W Rydlewska-Sadowska Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy Eur. Heart J., May 1, 2000; 21(9): 770 - 777. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
